HomeCompareTMRAY vs MRK

TMRAY vs MRK: Dividend Comparison 2026

TMRAY yields 1.83% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $10.8K in total portfolio value
10 years
TMRAY
TMRAY
● Live price
1.83%
Share price
$12.00
Annual div
$0.22
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$0.18
Full TMRAY calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — TMRAY vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTMRAYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TMRAY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TMRAY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TMRAY
Annual income on $10K today (after 15% tax)
$155.83/yr
After 10yr DRIP, annual income (after tax)
$0.15/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, MRK beats the other by $807.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TMRAY + MRK for your $10,000?

TMRAY: 50%MRK: 50%
100% MRK50/50100% TMRAY
Portfolio after 10yr
$25.4K
Annual income
$475.24/yr
Blended yield
1.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TMRAY
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
2.6
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TMRAY buys
0
MRK buys
0
No recent congressional trades found for TMRAY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTMRAYMRK
Forward yield1.83%3.25%
Annual dividend / share$0.22$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR-50%8.2%
Portfolio after 10y$20.0K$30.7K
Annual income after 10y$0.18$950.29
Total dividends collected$184.00$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: TMRAY vs MRK ($10,000, DRIP)

YearTMRAY PortfolioTMRAY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,792$91.67$11,192$351.54$400.00MRK
2$11,593$46.23$12,524$392.70$931.00MRK
3$12,428$23.21$14,015$438.65$1.6KMRK
4$13,310$11.62$15,682$489.96$2.4KMRK
5$14,247$5.82$17,547$547.23$3.3KMRK
6$15,247$2.91$19,632$611.16$4.4KMRK
7$16,316$1.46$21,963$682.53$5.6KMRK
8$17,459$0.73$24,571$762.18$7.1KMRK
9$18,681$0.36$27,486$851.08$8.8KMRK
10$19,989$0.18$30,745$950.29$10.8KMRK

TMRAY vs MRK: Complete Analysis 2026

TMRAYStock

Tomra Systems ASA provides sensor-based solutions for optimal resource productivity worldwide. It operates through three divisions: Collection, Recycling Mining, and Food. The Collection division engages in the development, production, sale, and service of reverse vending machines and related data management systems. This segment is also involved in picking up, transporting, and processing empty beverage containers on behalf of beverage producers/fillers. The Recycling Mining division offers sorting systems for waste and metal material streams; and ore sorting systems for the mining industry. The Food Solutions division provides post-harvest grading and sorting solutions for fresh produce; and sorting and processing technology for the processed food industries. The company was founded in 1972 and is headquartered in Asker, Norway.

Full TMRAY Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this TMRAY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TMRAY vs SCHDTMRAY vs JEPITMRAY vs OTMRAY vs KOTMRAY vs MAINTMRAY vs JNJTMRAY vs ABBVTMRAY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.